These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1416860)

  • 21. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.
    Wise R; Andrews JM; Piddock LJ
    J Antimicrob Chemother; 1985 Feb; 15(2):193-200. PubMed ID: 3980309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of resistance in gram-negative bacteria: a risk of broad-spectrum beta-lactam use.
    Dworzack DL
    Drug Intell Clin Pharm; 1986; 20(7-8):562-7. PubMed ID: 3488894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A; Klesel N; Wollmann T; Isert D; Limbert M; Schrinner E; Seibert G; Bauernfeind A; Jungwirth R; Wilhelm R
    J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R; Andrews JM; Cross C; Piddock LJ
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.
    Stone GW; Zhang Q; Castillo R; Doppalapudi VR; Bueno AR; Lee JY; Li Q; Sergeeva M; Khambatta G; Georgopapadakou NH
    Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of CGP 31608, a new penem.
    Wise R; Andrews JM; Piddock LJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formadicins, new monocyclic beta-lactam antibiotics of bacterial origin. I. Taxonomy, fermentation and biological activities.
    Katayama N; Nozaki Y; Okonogi K; Ono H; Harada S; Okazaki H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1117-27. PubMed ID: 3934120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
    Curtis NA; Orr D; Boulton MG; Ross GW
    J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro investigation of BK-218, a new oral and parenteral cephalosporin.
    Szabó I; Barabás J; Tar A; Kiss L; Filep M; Schmidt T; Marossy K; Tóth-Martinez B; Barabás G; Hernádi F
    Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
    Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S
    Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibacterial activity of ceftriaxone].
    Bergogne-Berezin E
    Rev Med Interne; 1985 Mar; 6(2):178-86. PubMed ID: 3873670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
    Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.